Adaptimmune Therapeutics PLC

Ownership Transactions Reported by 21 Insiders

Symbol: ADAP on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
Location: 60 Jubilee Avenue, Milton Park, Abingdon, Oxfordshire, United Kingdom

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	5	-196 K	100%	$0.78	-$152 K
Net	-5	-196 K	-100%		-$152 K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
E. Garry Menzel	Director	$50.5 K			Jul 1, 2024
Cintia Piccina	Chief Commercial Officer	$35.6 K	-$22.8 K	-39%	Jun 18, 2024
Adrian Rawcliffe	Chief Executive Officer, Director	$30.2 K	-$54.2 K	-64.2%	Jan 16, 2024
William Bertrand	Chief Operating Officer	$13.6 K	-$24.2 K	-64.1%	Jan 16, 2024
Elliot Norry	Chief Medical Officer	$13 K	-$24.1 K	-65.1%	Jan 16, 2024
John Lunger	Chief Patient Supply Officer	$12.8 K	-$26.5 K	-67.4%	Jan 16, 2024
Tal Zvi Zaks	Director				Jul 1, 2022
Joanna Brewer	Chief Scientific Officer				Jan 15, 2024
Priti Hegde	Director				Jul 1, 2024
Andrew Allen	Director				Jul 1, 2024
Gavin Wood	Chief Financial Officer				Jan 15, 2024
Barbara Gayle Duncan	Director				Jul 1, 2022
Charles Elliott Sigal	Director				Jul 3, 2023
David M. Mott	Director				Jul 1, 2024
EcoR1 Capital, LLC	10%+ Owner				Mar 8, 2024
Lawrence M. Alleva	Director				Jul 1, 2024
Ali Behbahani	Director				Jul 1, 2024
Kristen Hege	Director				Jul 1, 2024
James Noble	Director				Jul 1, 2022
Helen Tayton Martin	Chief Business & Strgy Officer				Jan 15, 2024
John Furey	Director				Jul 1, 2024

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership